Growth Metrics

MedWellAI (MWAI) Cash from Financing Activities (2016 - 2024)

MedWellAI has reported Cash from Financing Activities over the past 11 years, most recently at -$50000.0 for Q2 2024.

  • Quarterly Cash from Financing Activities changed N/A to -$50000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was -$50000.0 through Mar 2025, up 74.11% year-over-year, with the annual reading at -$243150.0 for FY2024, 386.3% down from the prior year.
  • Cash from Financing Activities was -$50000.0 for Q2 2024 at MedWellAI, up from -$94620.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $8.1 million in Q2 2021 and troughed at -$94620.0 in Q1 2024.
  • The 5-year median for Cash from Financing Activities is $2962.0 (2020), against an average of $941021.0.
  • The largest YoY upside for Cash from Financing Activities was 106985.39% in 2021 against a maximum downside of 103.63% in 2021.
  • A 5-year view of Cash from Financing Activities shows it stood at $226816.0 in 2020, then plummeted by 100.73% to -$1659.0 in 2021, then surged by 37360.4% to $618150.0 in 2022, then plummeted by 108.33% to -$51500.0 in 2023, then rose by 2.91% to -$50000.0 in 2024.
  • Per Business Quant, the three most recent readings for MWAI's Cash from Financing Activities are -$50000.0 (Q2 2024), -$94620.0 (Q1 2024), and -$51500.0 (Q4 2023).